| Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2017: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2016: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2015: ¥2,990,000 (Direct Cost: ¥2,300,000、Indirect Cost: ¥690,000)
|
|---|
| Outline of Final Research Achievements |
The historical trends of increasing prevalece of carbapenem-resistant Enterobacteriaceae (CRE) and the evolution of CRE strain types within hospital and community settings suggest that clinical issues with this pathogen will continue in the future.
Our results showed increasing prevalence of CRE in Japanese hospital. CRE was frequently detected in urine and sputum samples. Therefore, for the prevention of CRE transmission, implementing contact precaution procedures is a vital control method, along with the conventional hand hygiene practices. In addition, our results showed the new therapeutic target of CRE.
|
